UBS Group’s Eyegate Pharmaceuticals, Inc. Warrants EYEGW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-3,508
| Closed | – | – | 7736 |
|
|
2020
Q2 | $0 | Sell |
3,508
-277
| -7% | – | ﹤0.01% | 7547 |
|
|
2020
Q1 | $0 | Buy |
3,785
+185
| +5% | – | ﹤0.01% | 7458 |
|
|
2019
Q4 | $0 | Buy |
3,600
+3,490
| +3,173% | – | ﹤0.01% | 7365 |
|
|
2019
Q3 | $0 | Sell |
110
-2,435
| -96% | – | ﹤0.01% | 7318 |
|
|
2019
Q2 | $0 | Buy |
2,545
+2,000
| +367% | – | ﹤0.01% | 7303 |
|
|
2019
Q1 | $0 | Buy |
+545
| New | – | ﹤0.01% | 7308 |
|
|
2018
Q4 | – | Sell |
-4,300
| Closed | – | – | 7362 |
|
|
2018
Q3 | $0 | Buy |
+4,300
| New | – | ﹤0.01% | 7296 |
|